<?xml version="1.0" encoding="UTF-8"?>
<p id="Par18">PIZV is an aluminum hydroxide adjuvanted whole purified inactivated virus vaccine based on ZIKV strain PRVABC59 which was originally isolated from serum from a human infected in Puerto Rico (GenBank accession number KU501215). PIZV has been previously described and characterized by Baldwin 
 <italic>et al</italic>.
 <sup>
  <xref ref-type="bibr" rid="CR16">16</xref>
 </sup>. The same lot of PIZV used in this study was also used in clinical trial ZIK101 (ClinicalTrials.gov NCT03343626).
</p>
